From: Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction
No-DM Patients No. (109,247) | DM Patients No. (29,566) | P Value | DM Patients (duration of DM) No. (29,566) | P for trend | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Variables | < 5 years No. (6001) | 5–10 years No. (6677) | > 10 years No. (16,888) | |||||||
Age (years), mean ± SD | 72.7 ± 11.9 | 71.7 ± 9.6 | < 0.0001 | 71.1 ± 10.5 | 70.3 ± 10.0 | 72.5 ± 9.0 | < 0.0001 | |||
Age groups (years), n (%) | ||||||||||
50–64 | 31,376 (28.72) | 7424 (25.11) | < 0.0001 | 1803 (30.04) | 2098 (31.42) | 3523 (20.86) | < 0.0001 | |||
65–80 | 41,831 (38.29) | 15,281 (51.68) | 2723 (45.38) | 3223 (48.27) | 9335 (55.28) | |||||
> 80 | 36,040 (32.99) | 6861 (23.21) | 1475 (24.58) | 1356 (20.31) | 4030 (23.86) | |||||
Gender (female) | 40,094 (36.70) | 11,345 (38.37) | < 0.0001 | 1952 (32.53) | 2311 (34.61) | 7082 (41.94) | < 0.0001 | |||
AMI type | ||||||||||
STEMI | 52,753 (48.29) | 9937 (33.61) | < 0.0001 | 2309 (38.48) | 2494 (37.35) | 5134 (30.40) | < 0.0001 | |||
NSTEMI | 56,494 (51.71) | 19,629 (66.39) | < 0.0001 | 3692 (61.52) | 4183 (62.65) | 11,754(69.60) | < 0.0001 | |||
History of comorbidities, n (%) (in the previous 10 years) | ||||||||||
Cerebrovascular disease | 10,579 (9.68) | 5501 (18.61) | < 0.0001 | 868 (14.46) | 1028 (15.40) | 3605 (21.35) | < 0.0001 | |||
Prior myocardial infarction | 4935 (4.52) | 4289 (14.51) | < 0.0001 | 969 (16.15) | 871 (13.04) | 2449 (14.50) | < 0.0001 | |||
Chronic ischemic heart disease | 13,320 (12.19) | 8307 (28.10) | < 0.0001 | 1370 (22.83) | 1570 (23.65) | 5358 (31.73) | < 0.0001 | |||
Prior PCI or CABG | 9839 (9.01) | 6371 (21.55) | < 0.0001 | 1208 (20.13) | 1317 (19.72) | 3846 (22.77) | < 0.0001 | |||
Chronic heart failure | 1660 (1.52) | 1206 (4.08) | < 0.0001 | 186 (3.10) | 214 (3.21) | 806 (4.77) | < 0.0001 | |||
Atrial fibrillation | 7394 (6.77) | 3075 (10.40) | < 0.0001 | 546 (9.10) | 684 (10.24) | 1845 (10.92) | 0.0003 | |||
Peripheral vascular disease | 4322 (3.96) | 4746 (16.05) | < 0.0001 | 541 (9.02) | 762 (11.41) | 3443 (20.39) | < 0.0001 | |||
Lower limb complication | 975 (0.89) | 1601 (5.42) | < 0.0001 | 163 (2.72) | 197 (2.95) | 1241 (7.35) | < 0.0001 | |||
Renal disease | 4581 (4.19) | 3419 (11.56) | < 0.0001 | 417 (6.95) | 519 (7.77) | 2483 (14.70) | < 0.0001 | |||
COPD | 6209 (5.68) | 2505 (8.47) | < 0.0001 | 502 (8.37) | 543 (8.13) | 1460 (8.65) | 0.4201 | |||
Cancer | 16.468 (15.07) | 5255 (17.77) | < 0.0001 | 1000 (16.66) | 1193 (17.87) | 3962 (18.13) | 0.0374 | |||
Antihyperglicemic drugs (12 months before index AMI hospitalization) | ||||||||||
Insulin | 0 (0.00) | 10,795 (36.51) | < 0.0001 | 1052 (17.53) | 1263 (18.92) | 8480 (50.21) | < 0.0001 | |||
Other AHAs | 0 (0.00) | 29,392 (99.41) | < 0.0001 | 5998 (99.95) | 6581 (98.56) | 16,813 (99.56) | < 0.0001 | |||
Other medications of interest (12 months before index AMI hospitalization) | ||||||||||
ACE-I/ARBS | 51,901 (47.51) | 21,020 (71.10) | < 0.0001 | 3989 (66.47) | 4541 (68.01) | 12,490 (73.96) | < 0.0001 | |||
Beta blockers | 31,605 (28.93) | 14,365 (48.59) | < 0.0001 | 2774 (46.23) | 3057 (45.78) | 8534 (50.53) | < 0.0001 | |||
Diuretics | 19,686 (17.93) | 11,164 (37.75) | < 0.0001 | 1822 (30.36) | 2118 (31.72) | 7224 (42.78) | < 0.0001 | |||
Ca-antagonists | 24,179 (22.13) | 11,459 (38.76) | < 0.0001 | 1985 (33.08) | 2298 (34.42) | 7176 (42.49) | < 0.0001 | |||
Lipid lowering drugs | 28,353 (25.95) | 16,972 (57.40) | < 0.0001 | 3240 (53.99) | 3561 (53.33) | 10,171 (60.23) | < 0.0001 | |||
Antiplatelet drugs | 33,288 (30.47) | 17,071 (57.74) | < 0.0001 | 3034 (50.56) | 3427 (51.33) | 10,610 (62.83) | < 0.0001 | |||
Oral anticoagulant drugs | 6570 (6.01) | 2764 (9.35) | < 0.0001 | 526 (8.77) | 607 (9.09) | 1631 (9.66) | 0.0890 |